These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 32110014

  • 1. A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies.
    Huang S, Huang Z, Fu Z, Shi Y, Dai Q, Tang S, Gu Y, Xu Y, Chen J, Wu X, Ren F.
    Int J Nanomedicine; 2020; 15():1161-1172. PubMed ID: 32110014
    [Abstract] [Full Text] [Related]

  • 2. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L, Chen B, Deng L, Gao B, Zhang Y, Wu C, Yu N, Zhou Q, Yao J, Chen J.
    Int J Pharm; 2017 Dec 20; 534(1-2):308-315. PubMed ID: 28986321
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.
    Luo JW, Zhang ZR, Gong T, Fu Y.
    Int J Nanomedicine; 2016 Dec 20; 11():1051-65. PubMed ID: 27042060
    [Abstract] [Full Text] [Related]

  • 8. Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca2+ channel blocker nimodipine drug molecules.
    Janovák L, Turcsányi Á, Bozó É, Deák Á, Mérai L, Sebők D, Juhász Á, Csapó E, Abdelghafour MM, Farkas E, Dékány I, Bari F.
    Eur J Pharm Sci; 2018 Oct 15; 123():79-88. PubMed ID: 30026092
    [Abstract] [Full Text] [Related]

  • 9. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
    Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, Liu X, Sun Y, Sui X, Luo C, Sun L, Han X, Lian H, Zhu M, Wang S, He Z.
    Colloids Surf B Biointerfaces; 2013 Sep 01; 109():161-6. PubMed ID: 23668980
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.
    Teng Z, Yu M, Ding Y, Zhang H, Shen Y, Jiang M, Liu P, Opoku-Damoah Y, Webster TJ, Zhou J.
    Int J Nanomedicine; 2019 Sep 01; 14():119-133. PubMed ID: 30613141
    [Abstract] [Full Text] [Related]

  • 12. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine.
    Kale AA, Patravale VB.
    AAPS PharmSciTech; 2008 Sep 01; 9(1):191-6. PubMed ID: 18446481
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S, Wang J, Pan J.
    Drug Deliv; 2016 Nov 01; 23(9):3696-3703. PubMed ID: 27749105
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of an intravenous injectable nimodipine nanosuspension in mice.
    Xiong R, Lu W, Yue P, Xu R, Li J, Chen T, Wang P.
    J Pharm Pharmacol; 2008 Sep 01; 60(9):1155-9. PubMed ID: 18718118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.